Crossmark

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options

Crossref DOI link: https://doi.org/10.1186/s12981-025-00775-z

Published Online: 2025-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fokam, Joseph

Anim-Keng, Tekoh Tatiana

Pokam, Benjamin Thumamo

Chenwi, Collins Ambe

Ka’e, Aude Christelle

Semengue, Ezechiel Ngoufack Jagni

Beloumou Angong, Odile Estelle Grâce

Takou, Desire

Nka, Alex Durand

Djupsa, Sandrine

Etame, Naomi-Karell

Molimbou, Evariste

Ajeh, Rogers

Bissek, Anne-Cecile Z-K

Colizzi, Vittorio

Perno, Carlo-Federico

Halle-Ekane, Gregory-Edie

Ndembi, Nicaise

Ndjolo, Alexis
License Information

Text and Data Mining valid from 2025-09-30

Version of Record valid from 2025-09-30
More Information

Article History

Received: 1 March 2025

Accepted: 22 July 2025

First Online: 30 September 2025

Declarations

:

: Ethical clearance was obtained from the University of Buea, Faculty of Health Sciences (FHS) Institutional Review Board (Ref. N° 2023/1945-01/UB/SG/IRB/FHS), administrative authorization obtained from the Director of CIRCB (Ref. N° 2112/016L/CIRCB/DIR/CL). A certified module on research ethics, the Training and Resources in Research Ethics Evaluation (TRREE-) was completed. The study was conducted according to the ethical principles outlined in the Declaration of Helsinki. Consent was waived as the research was carried out on stored samples.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below